Evidence map›Paper›PMID 30718956›Full record

ArticleNeuropsychiatric disease and treatment2019

Cytokines and chemokines expression in serum of patients with neuromyelitis optica.

Nanping Ai, Hongjuan Liu, Huanfen Zhou, Dahe Lin, Junqing Wang, Mo Yang, Honglu Song, Mingming Sun, Quangang Xu, Shihui Wei

Open access · goldAbstract read
In one paragraph

Article in Neuropsychiatric disease and treatment, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. NMOSD IgG Impact Retinal Cells in Murine Retinal Explants.Current issues in molecular biology · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Serum Contactin-1 in CIDP: A Cross-Sectional Study.Neurology(R) neuroimmunology & neuroinflammation · 2021
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Nanping AiDepartment of Ophthalmology, Chinese PLA General Hospital, Beijing 100853, People's Republic of China, weishihui58@126.com.
Hongjuan LiuDepartment of Ophthalmology, Chinese PLA General Hospital, Beijing 100853, People's Republic of China, weishihui58@126.com.
Huanfen ZhouDepartment of Ophthalmology, Chinese PLA General Hospital, Beijing 100853, People's Republic of China, weishihui58@126.com.
Dahe LinDepartment of Ophthalmology, Chinese PLA General Hospital, Beijing 100853, People's Republic of China, weishihui58@126.com.
Junqing WangDepartment of Ophthalmology, Chinese PLA General Hospital, Beijing 100853, People's Republic of China, weishihui58@126.com.
Mo YangDepartment of Ophthalmology, Chinese PLA General Hospital, Beijing 100853, People's Republic of China, weishihui58@126.com.
Honglu SongDepartment of Ophthalmology, Chinese PLA General Hospital, Beijing 100853, People's Republic of China, weishihui58@126.com.
Mingming SunDepartment of Ophthalmology, Chinese PLA General Hospital, Beijing 100853, People's Republic of China, weishihui58@126.com.
Quangang XuDepartment of Ophthalmology, Chinese PLA General Hospital, Beijing 100853, People's Republic of China, weishihui58@126.com.
Shihui WeiDepartment of Ophthalmology, Chinese PLA General Hospital, Beijing 100853, People's Republic of China, weishihui58@126.com.
Chinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo study the differences in immunopathogenesis based on chemokine profile in neuromyelitis optica patients positive for AQP4 antibodies or MOG antibodies. PATIENTS AND

methodsWe measured 52 cytokines/chemokines using ELISA in 59 serum samples, which were divided into three groups according to CBA results: HCs (n=16), AQP4+ (n=20) and MOG+ (n=23). The regression equation (

resultsEleven of 52 measured serum cytokine/chemokines (CCL22/MDC, CCL13/MCP-4, CCL21/6Ckine, CCL27/CTACK, CCL8/MCP-2, CXCL14/BRAK, Contactin-1, Kallilrein 6/Neurosin, Midkine, VCAM-1 and Fas) were significantly different between MOG+ group and controls. Ten of 52 measured serum cytokine/chemokines (CCL1/I-309, CCL22/MDC, CCL28, CCL17/TARC, CCL27/CTACK, CXCL2/GRO beta, Contactin-1, Midkine, Chemerin and Synuclein-alpha) were significantly different between AQP4+ group and controls. There was no difference between serum AQP4+ and MOG+ groups for CC chemokines. All measured chemokines CXC except CXCL6/GCP-2 showed no significant differences in serum AQP4+ group compared to MOG+ group. However, there was significant difference between serum AQP4+ and MOG+ groups for C5/C5a and Midkine. C5/C5a and Midkine were significantly higher in AQP4+ group compared to MOG+ group (

conclusionOur findings suggest that the differences of mean concentration in CXCL6/GCP-2, Midkine and C5/C5a probably reveal different immunologic mechanism between AQP4+ NMO and MOG+ NMO. This cytokine/chemokine profiling provides new insight into NMO pathogenesis associated with MOG antibody seropositivity and provides guidance to monitor inflammation and response to treatment in a way.

Indexed as

AQP4 antibodieschemokinescytokinesMOG antibodiesNMO

Identifiers

PMID30718956
PMCPMC6345185
OpenAlexW2910711926

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.